InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.16
(
0.21%
)
Bitcoin
68,784.64
(
0.40%
)
Post# of 251942
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119691
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 202873

Wednesday, 10/26/2016 10:08:31 AM

Wednesday, October 26, 2016 10:08:31 AM

Post# of 251942
EXAS -14% on 3Q16 results and non-raised full-year 2016 guidance:

http://finance.yahoo.com/news/exact-sciences-completes-68-000-100000979.html

The number of tests in 3Q16 was 68K, and the guidance for full-year 2016 remains 240K tests. Inasmuch as EXAS performed ~160K tests during the first 9 months of 2016, the full-year guidance equates to ~80K tests during 4Q16.

Meanwhile, the compliance rate continues to slip—during the 12-month period from 8/1/15 to 7/31/16 it was down to 67%. (This means that 1/3 of patients who received Cologuard never sent in the materials for analysis.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up